Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.
- DOI
- 10.1002/pros.70175
- Published
- 2026 Jun
- Container
- The Prostate
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/pros.70175,
title = {Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.},
author = {Deivasigamani S and Kotamarti S and Mottaghi M and Adams ES and Ghoreifi A and Jhaveri H and Seguier D and Ivey MC and Zambon JP and Podichetty A and Can T and Groshopf J and Gupta RT and Moul JW and Polascik TJ},
year = {2026},
journal = {The Prostate},
doi = {10.1002/pros.70175},
url = {https://doi.org/10.1002/pros.70175}
}RIS
TY - JOUR TI - Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy. AU - Deivasigamani S AU - Kotamarti S AU - Mottaghi M AU - Adams ES AU - Ghoreifi A AU - Jhaveri H AU - Seguier D AU - Ivey MC AU - Zambon JP AU - Podichetty A AU - Can T AU - Groshopf J AU - Gupta RT AU - Moul JW AU - Polascik TJ PY - 2026 JO - The Prostate DO - 10.1002/pros.70175 UR - https://doi.org/10.1002/pros.70175 ER -
APA
S, D., S, K., M, M., ES, A., A, G., H, J., D, S., MC, I., JP, Z., A, P., T, C., J, G., RT, G., JW, M., & TJ, P. (2026). Genomic Prostate Score (GPS) as a Prognostic Biomarker in Patients With Localized Prostate Cancer Undergoing Focal Therapy.. The Prostate. https://doi.org/10.1002/pros.70175
Source records
- pubmed · retrieved 2026-09-26T16:22:45.812Z